Welcome to LookChem.com Sign In|Join Free
  • or
5-AMINOPENTANOIC ACID-BENZYL ESTER P-TOSYLATE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

63649-14-9

Post Buying Request

63649-14-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

63649-14-9 Usage

Chemical Properties

White Solid

Check Digit Verification of cas no

The CAS Registry Mumber 63649-14-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,6,4 and 9 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 63649-14:
(7*6)+(6*3)+(5*6)+(4*4)+(3*9)+(2*1)+(1*4)=139
139 % 10 = 9
So 63649-14-9 is a valid CAS Registry Number.

63649-14-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl 5-aminopentanoate,4-methylbenzenesulfonic acid

1.2 Other means of identification

Product number -
Other names 5-Aminopentanoic Acid Benzyl Ester Tosylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:63649-14-9 SDS

63649-14-9Relevant academic research and scientific papers

DELIVERY OF TARGET SPECIFIC NUCLEASES

-

Paragraph 0456, (2018/06/30)

Described herein are lipid nanoparticles comprising cationic lipids and other lipids and also comprising engineered nucleases facilitate transfer of nucleic acids to cells.

LIPID DELIVERY OF THERAPEUTIC AGENTS TO ADIPOSE TISSUE

-

Page/Page column 159-160; 167-168, (2018/11/10)

A method of treating a disease mediated by protein expression in adipose tissue by intraperitoneally administering a composition comprising a lipid nanoparticle encapsulating or associated with a therapeutic agent (e.g., a nucleic acid), thereby delivering the therapeutic agent to adipose tissue of the subject and altering protein expression in the adipose tissue is provided herein. A method for delivering a therapeutic agent to adipose tissue of a subject in need thereof is also provided.

Molecular structural requirements, dye specificity, and application of anionic peptide amphiphiles that induce intense fluorescence in cationic dyes

Hachisako, Hiroshi,Ryu, Naoya,Murakami, Ryoichi

supporting information; experimental part, p. 2327 - 2337 (2009/09/26)

We have previously reported that a double-chain anionic amphiphile capable of intermolecular triple hydrogen bonds could form extremely hydrophobic sites in water and specifically incorporated stilbazolium-based compact hemicyanine dyes as monomeric species, resulting in induction of intense fluorescence emission in the dyes. In this paper, the structural requirements of the intense fluorescence-inducing amphiphiles were investigated. It is noted that the introduction of β-Ala residues into two long-chain alkyl group moieties was most effective for the amphiphiles derived from L-glutamic acid with relatively shorter side-chain methylenes. The dye specificity in terms of induction of the intense fluorescence was also investigated using hemicyanines (stilbazolium etc.), cyanine, carbocyanine, thiacarbocyanines, and azo dye. The amphiphile with the shortest octanoyl-β-alanyl double-chain alkyl groups, longer side-chain, and shorter spacer was found to show increased sensitivity to alkali metal ions, especially Li+. This could be a potential OFF-ON type fluorescence sensor for Li+. The Royal Society of Chemistry 2009.

Semisynthesis of RPR 121056A, a major metabolite of irinotecan (CPT-11)

Bourzat, Jean-Dominique,Vuilhorgne, Marc,Rivory, Laurent P.,Robert, Jacques,Commercon, Alain

, p. 6327 - 6330 (2007/10/03)

The semisynthesis of RPR 121056A (4), a major metabolite of irinotecan (CPT-11, 2) is reported starting from SN-38 (3) and an appropriate side-chain precursor, and using a 2-step sequence. This semisynthesis is based on the 10-O-acylation of SN-38 with the conveniently protected carbamoylchloride derivative 10 followed by cleavage of the benzylic protecting groups by hydrogenolysis. Preliminary in vitro results show that RPR 121056A displays no cytotoxicity.

2 AND 3-SUBSTITUTED ENKEPHALINS

-

, (2008/06/13)

Analogs of enkephalin having agonist activity at opiate receptors are disclosed herein. These analogs are useful as analgesics, non-addicting narcotic antagonists and anti-diarrheal agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 63649-14-9